Synaptide

Active Risk: not assessed

Private limited companyfounded 2025active for less than a yearAvenue Reine Fabiola 14, 1340 Ottignies-Louvain-la-Neuve, BelgiumKBO/BCE: BE 1029.861.866

Summary

Synaptide is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. No annual accounts have been filed with the National Bank; this conclusion rests only on the KBO register and the Belgian Official Gazette.

Risk analysisFollow Report Compare

SynaptideActive

Risk analysis Report Compare

History

Synaptide was incorporated on 31 October 2025 as a private limited company by one natural person, with a starting capital of €3,000.¹² Since 2025, LEROY Eric Jean-Paul has served as non-statutory director of the company.²

Acts, filings and financial milestones

All 1Gazette 1

2025

04-11

Gazette deed Incorporation

Appointment: LEROY Eric Jean-Paul (non-statutory director) · Capital · Registered office clause7 facts ▸

Incorporation, 30-10-2025
Capital
Registered office clause, “1340 Ottignies-Louvain-la-Neuve, Avenue Reine Fabiola”, 14 (deed in French)
Director appointment, LEROY Eric Jean-Paul (non-statutory director)
Pre-incorporation commitments, “takeover, tous les engagements, obligations et activités entreprises au nom et pour compte de la société en formation” (deed in French)
Founding capital, €3,000
Shareholding, 30-10-2025, “actions” (deed in French)

Gazette deed

1 of 1 deed read